Detalhe da pesquisa
1.
Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma-a single-center retrospective study.
Neurol Sci
; 45(6): 2931-2934, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326666